Cargando…

Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease

Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Borges, Natalia, Espinosa, Juan Carlos, Marín-Moreno, Alba, Aguilar-Calvo, Patricia, Asante, Emmanuel A., Kitamoto, Tetsuyuki, Mohri, Shirou, Andréoletti, Olivier, Torres, Juan María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572891/
https://www.ncbi.nlm.nih.gov/pubmed/28820136
http://dx.doi.org/10.3201/eid2309.161948
_version_ 1783259583393824768
author Fernández-Borges, Natalia
Espinosa, Juan Carlos
Marín-Moreno, Alba
Aguilar-Calvo, Patricia
Asante, Emmanuel A.
Kitamoto, Tetsuyuki
Mohri, Shirou
Andréoletti, Olivier
Torres, Juan María
author_facet Fernández-Borges, Natalia
Espinosa, Juan Carlos
Marín-Moreno, Alba
Aguilar-Calvo, Patricia
Asante, Emmanuel A.
Kitamoto, Tetsuyuki
Mohri, Shirou
Andréoletti, Olivier
Torres, Juan María
author_sort Fernández-Borges, Natalia
collection PubMed
description Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)) can be encoded. To date, all clinical and neuropathologically confirmed vCJD cases have been Met(129) homozygous, with the exception of 1 recently reported Met/Val heterozygous case. Here, we found that transgenic mice homozygous for Val(129) Hu-PrP show severely restricted propagation of the BSE prion strain, but this constraint can be partially overcome by adaptation of the BSE agent to the Met(129) Hu-PrP. In addition, the transmission of vCJD to transgenic mice homozygous for Val(129) Hu-PrP resulted in a prion with distinct strain features. These observations may indicate increased risk for vCJD secondary transmission in Val(129) Hu-PrP–positive humans with the emergence of new strain features.
format Online
Article
Text
id pubmed-5572891
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-55728912017-09-02 Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease Fernández-Borges, Natalia Espinosa, Juan Carlos Marín-Moreno, Alba Aguilar-Calvo, Patricia Asante, Emmanuel A. Kitamoto, Tetsuyuki Mohri, Shirou Andréoletti, Olivier Torres, Juan María Emerg Infect Dis Research Bovine spongiform encephalopathy (BSE) is the only known zoonotic prion that causes variant Creutzfeldt-Jakob disease (vCJD) in humans. The major risk determinant for this disease is the polymorphic codon 129 of the human prion protein (Hu-PrP), where either methionine (Met(129)) or valine (Val(129)) can be encoded. To date, all clinical and neuropathologically confirmed vCJD cases have been Met(129) homozygous, with the exception of 1 recently reported Met/Val heterozygous case. Here, we found that transgenic mice homozygous for Val(129) Hu-PrP show severely restricted propagation of the BSE prion strain, but this constraint can be partially overcome by adaptation of the BSE agent to the Met(129) Hu-PrP. In addition, the transmission of vCJD to transgenic mice homozygous for Val(129) Hu-PrP resulted in a prion with distinct strain features. These observations may indicate increased risk for vCJD secondary transmission in Val(129) Hu-PrP–positive humans with the emergence of new strain features. Centers for Disease Control and Prevention 2017-09 /pmc/articles/PMC5572891/ /pubmed/28820136 http://dx.doi.org/10.3201/eid2309.161948 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Fernández-Borges, Natalia
Espinosa, Juan Carlos
Marín-Moreno, Alba
Aguilar-Calvo, Patricia
Asante, Emmanuel A.
Kitamoto, Tetsuyuki
Mohri, Shirou
Andréoletti, Olivier
Torres, Juan María
Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
title Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
title_full Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
title_fullStr Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
title_full_unstemmed Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
title_short Protective Effect of Val(129)-PrP against Bovine Spongiform Encephalopathy but not Variant Creutzfeldt-Jakob Disease
title_sort protective effect of val(129)-prp against bovine spongiform encephalopathy but not variant creutzfeldt-jakob disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572891/
https://www.ncbi.nlm.nih.gov/pubmed/28820136
http://dx.doi.org/10.3201/eid2309.161948
work_keys_str_mv AT fernandezborgesnatalia protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT espinosajuancarlos protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT marinmorenoalba protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT aguilarcalvopatricia protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT asanteemmanuela protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT kitamototetsuyuki protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT mohrishirou protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT andreolettiolivier protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease
AT torresjuanmaria protectiveeffectofval129prpagainstbovinespongiformencephalopathybutnotvariantcreutzfeldtjakobdisease